Hernandez, R. K., Critchlow, C. W., Dreyer, N., Lash, T. L., Reynolds, R. F., Sørensen, H. T., Lange, J. L., Gatto, N. M., Sobel, R. E., Lai, E. C., Schoonen, M., Brown, J. S., Christian, J. B., Brookhart, M. A., & Bradbury, B. D. (2025). Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real‐World Evidence. Clinical Pharmacology & Therapeutics. Portico. https://doi.org/10.1002/cpt.3563

Men, X., Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Reynolds, C. F., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2024). CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression. Clinical Pharmacology & Therapeutics, 115(5), 1065–1074. Portico. https://doi.org/10.1002/cpt.3162

Magarbeh, L., Hassel, C., Choi, M., Islam, F., Marshe, V. S., Zai, C. C., Zuberi, R., Gammal, R. S., Men, X., Scherf‐Clavel, M., Enko, D., Frey, B. N., Milev, R., Soares, C. N., Parikh, S. V., Placenza, F., Strother, S. C., Hassel, S., Taylor, V. H., … Müller, D. J. (2023). ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study. Clinical Pharmacology & Therapeutics, 114(1), 88–117. Portico. https://doi.org/10.1002/cpt.2854

Chiwambutsa, S. M., Ayeni, O., Kapungu, N., Kanji, C., Thelingwani, R., Chen, W. C., Mokone, D. H., O’Neil, D. S., Neugut, A. I., Jacobson, J. S., Ruff, P., Cubasch, H., Joffe, M., & Masimirembwa, C. (2023). Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co‐Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer. Clinical Pharmacology & Therapeutics, 114(1), 127–136. Portico. https://doi.org/10.1002/cpt.2904